UKAD 2022 UKAD vs Joshua Hicks

In December 2022 United Kingdom Anti-Doping (UKAD) reported an anti-doping rule violation against the rugby player Joshua Hicks after his sample tested positive for multiple prohibited substances: Anastrozole, Drostanolone and Tamoxifen.

Following notification a provisional suspension was ordered and the Athlete admitted the violation. He stated that he had used the substances before the rugby season had begun while he was unaware that these substances were prohibited.

At first in March 2023 the Athlete did not accept the proposed sanction and the case was referred to the National Anti-Doping Panel. Ultimately in June 2023 he admitted the violation, waived his right for a hearing and accepted the sanction proposed by UKAD.

Therefore UKAD decides on 25 August 2023 to impose a 4 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 16 December 2022.

Original document

Parameters

Legal Source
National Decisions
Date
25 August 2023
Original Source
UK Anti-Doping (UKAD)
Country
United Kingdom
Language
English
ADRV
Adverse Analytical Finding / presence
Legal Terms
Acceptance of sanction
Admission
Waiver of "right to be heard"
Sport/IFs
Rugby (WR) - World Rugby
Other organisations
UK Anti-Doping (UKAD)
Welsh Rugby Union (WRU)
Laboratories
London, United Kingdom: Drug Control Centre
Doping classes
S1. Anabolic Agents
S4. Hormone And Metabolic Modulators
Substances
Anastrozole
Drostanolone
Selective estrogen receptor modulators (SERMS)
Tamoxifen
Document type
Pdf file
Date generated
11 October 2023
Date of last modification
30 October 2023
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin